Ambu A/S (OTCMKTS:AMBBY) Sees Strong Trading Volume – Should You Buy?

Shares of Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) saw an uptick in trading volume on Thursday. 1,000 shares were traded during trading, an increase of 55% from the average daily volume of 644 shares. The stock last traded at $13.60 and had previously closed at $12.10.

Wall Street Analyst Weigh In

Separately, UBS Group downgraded Ambu A/S from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 15th. One analyst has rated the stock with a Hold rating. According to data from MarketBeat.com, the stock has a consensus rating of “Hold”.

Ambu A/S Stock Performance

The firm has a market capitalization of $3.05 billion, a PE ratio of 35.14 and a beta of 0.86. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.69 and a current ratio of 2.77. The business’s fifty day simple moving average is $11.15 and its 200-day simple moving average is $10.98.

Ambu A/S (OTCMKTS:AMBBY) last issued its earnings results on Thursday, November 5th. The company reported $0.14 earnings per share for the quarter. Ambu A/S had a net margin of 8.18% and a return on equity of 8.49%.

Ambu A/S Company Profile

Ambu A/S is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. Its products are designed to support clinical procedures while reducing the need for cleaning, disinfection and reprocessing associated with reusable equipment.

The company’s portfolio includes single-use endoscopy systems, such as the aScope range of flexible endoscopes and related visualization equipment, as well as products for anesthesia, airway management, ventilation, resuscitation and patient monitoring.